Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 7,750 shares at $51.30 ($391K) on 2021-12-15, disclosed to the SEC on 2021-12-17.
Open-market sale of $391k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.41 | 1,716 | $85K | 21.7% |
| 2 | $49.41 | 1,716 | $85K | 21.7% |
| 3 | $50.60 | 1,050 | $53K | 13.6% |
| 4 | $51.30 | 1,034 | $53K | 13.6% |
| 5 | $51.30 | 1,034 | $53K | 13.6% |
| 6 | $52.20 | 1,200 |
| $63K |
| 16.0% |
| Total | $50.51 avg | 7,750 | $391K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |